CGON · Insider trading · 13F holders · Congress trades
CG Oncology, Inc. (CGON)
Who is buying and selling CGON: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 23
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $210K
- Congress trades, 12 months
- 0
CGON at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 CGON insider filed 3 sales worth $210K on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
- 23 13F filers hold CGON among their 50 largest positions, worth $2.4B combined, including Oleg Nodelman. The biggest bets by portfolio weight are Decheng Capital LLC (61.9%), Foresite Capital Management VI LLC (26.2%) and Seven Fleet Capital Management LP (22.1%). In their latest 13Fs, 2 managers opened a new position and 7 added to one.
- No member of Congress has disclosed a trade in CGON.
- CGON last closed at $63.47 on Oct 29, 2026.
CGON insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 CGON insider filed 3 sales worth $210K on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 19, 2026 | Post Leonard E | Director | Sale10b5-1 | 1,000 | $62.07 | $62K | SEC |
| Sep 17, 2026 | Post Leonard E | Director | Sale10b5-1 | 1,000 | $72.98 | $73K | SEC |
| Aug 18, 2026 | Post Leonard E | Director | Sale10b5-1 | 1,000 | $74.54 | $75K | SEC |
Who owns CGON? Hedge funds and superinvestors
23 13F filers hold CGON among their 50 largest positions, worth $2.4B combined, including Oleg Nodelman. The biggest bets by portfolio weight are Decheng Capital LLC (61.9%), Foresite Capital Management VI LLC (26.2%) and Seven Fleet Capital Management LP (22.1%). In their latest 13Fs, 2 managers opened a new position and 7 added to one.
Superinvestors holding CGON: Oleg Nodelman 5.3%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Rtw Investments, LPHedge fund | 5.2% | $605.0M | 8,514,590 | +21.9% shares | Q2 2026 |
| Decheng Capital LLCHedge fund | 61.9% | $452.7M | 6,371,669 | +0.0% shares | Q2 2026 |
| TCG Crossover Management, LLCHedge fund | 6.3% | $260.8M | 3,670,206 | +0.0% shares | Q2 2026 |
| Foresite Capital Management VI LLCHedge fund | 26.2% | $168.4M | 2,369,574 | +6.7% shares | Q2 2026 |
| Seven Fleet Capital Management LPHedge fund | 22.1% | $134.0M | 1,886,236 | +2389.8% shares | Q2 2026 |
| Oleg NodelmanHedge fund | 5.3% | $106.2M | 1,494,300 | +35.6% shares | Q2 2026 |
| DV Trading LLCInvestment manager | 8.5% | $102.3M | 1,439,393 | +0.0% shares | Q2 2026 |
| Avidity Partners Management LPHedge fund | 15.9% | $99.4M | 1,398,948 | New | Q2 2026 |
| Acorn Capital Advisors, LLCHedge fund | 21.9% | $80.4M | 1,131,500 | +0.1% shares | Q2 2026 |
| Foresite Capital Management V, LLCHedge fund | 21.2% | $76.7M | 1,079,050 | +7.5% shares | Q2 2026 |
| Logos Global Management LPHedge fund | 3.1% | $71.0M | 1,000,000 | +73.9% shares | Q2 2026 |
| Orbimed Advisors LLCHedge fund | 1.3% | $69.1M | 972,800 | +2.6% shares | Q2 2026 |
| Jefferies Financial Group Inc.Broker-dealer | 0.5% | $54.7M | 769,947 | — | Q2 2026 |
| Bellevue Group AGInvestment manager | 0.7% | $35.1M | 493,596 | — | Q2 2026 |
| Caption Management, LLCHedge fund | 1.2% | $34.4M | 484,461 | +28.0% shares | Q2 2026 |
| Stempoint Capital LPHedge fund | 2.0% | $11.3M | 159,349 | -22.5% shares | Q2 2026 |
| PFM Health Sciences, LPHedge fund | 0.8% | $9.1M | 128,286 | -22.7% shares | Q2 2026 |
| Lynx1 Capital Management LPHedge fund | 0.3% | $2.2M | 31,391 | -0.6% shares | Q2 2026 |
| Renaissance Capital LLCMutual fund manager | 1.3% | $1.9M | 27,173 | — | Q3 2026 |
| Sicart Associates LLCWealth manager | 0.4% | $1.5M | 25,000 | +0.0% shares | Q3 2026 |
| Ami Asset Management CorpWealth manager | 0.1% | $1.2M | 17,271 | -11.0% shares | Q3 2026 |
| Ground Swell Capital, LLCHedge fund | 0.4% | $339K | 4,765 | — | Q2 2026 |
| DeepCurrents Investment Group LLCHedge fund | 0.4% | $294K | 4,133 | New | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 3, Q2 2026: 20). Screen CGON in the grand portfolio →
CGON stock trades by members of Congress
No member of Congress has disclosed a trade in CGON.
Analysis mentioning CGON
Posts from the blog that cover CG Oncology, Inc., newest first.
CGON questions and answers
Are insiders buying CGON stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 CGON insider filed 3 sales worth $210K on SEC Form 4, and no open-market purchases; 3 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own CGON?
23 13F filers hold CGON among their 50 largest positions, worth $2.4B combined, including Oleg Nodelman. The biggest bets by portfolio weight are Decheng Capital LLC (61.9%), Foresite Capital Management VI LLC (26.2%) and Seven Fleet Capital Management LP (22.1%). In their latest 13Fs, 2 managers opened a new position and 7 added to one.
Has Congress traded CGON?
No member of Congress has disclosed a trade in CGON.
Who is the largest holder of CGON?
Among 13F filers, Rtw Investments, LP reports the largest CGON position, $605.0M (8,514,590 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Decheng Capital LLC's: 61.9% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.